The purpose/mission of the National Brain Injury Foundation is to provide social support groups, advocacy, and information to people with brain injuries and their families.

Wednesday, September 19, 2012

Traumatic Brain Injury Drug Exceeds Expectations In Phase IIa Exploratory Clinical Trial

Vasopharm GmbH, a pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases, today announces that the explorative phase IIa NOSTRA trial in Traumatic Brain Injury Patients met all clinical endpoints for safety and in addition demonstrated strong evidence of clinical benefit in patients.